Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 12 results found. Search for [ mankind pharma news India ]

Results 1 to 12 of 12
BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Reliance Jio is also working on its 5G network equipment and has asked the Department of Telecom (DoT) to allocate spectrum for testing before exporting 5G smartphones


BusinessToday.In
October 19, 2020
Chebrolu's invention is based on in-silico methodology. In this, a lead molecule selectively binds with spike protein of COVID-19. She is now planning to work with scientists who are working tirelessly to find vaccine against COVID-19


Rashi Bisaria
New Delhi, October 19, 2020
Reliance Jio plans to sells 5G smartphones at Rs 2,500-3,000Reliance Jio is planning to launch a 5G smartphone for less than Rs 5,000 and gradually reduce the price to Rs 2,500-3,000 a unit when it scales up the operation, according to a company official. The company will target 20-30 crore mobile phone users who use 2G connection at present.Coronavirus impact: Passenger vehicle exports dip 57.52% in Apr-SepPassenger vehicle exports bore the brunt of the pandemic in April-September period....


Joe C Mathew
October 18, 2020
Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the coming months


PB Jayakumar
September 2, 2020
Mankind has been promoting DrOnA Health among doctors as a service to help them. Over 10,000 doctors are now using the facility. Another special feature of the app is that it allows doctors to have complete ownership of data.


PB Jayakumar
March 31, 2020
Corporate groups like the Sajjan Jindal Group and Anil Agarwal-led Vedanta had earlier committed Rs 100 crore each, besides a Rs 1,500 crore commitment from the Tata Group


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


PTI
March 6, 2019



E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.


P.B. Jayakumar, E. Kumar Sharma and Venkatesha Babu
June 17, 2015
Most of them started with very little capital and resources. And all of them persevered through the bad times of the industry.


PAGES 1 OF 1